Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Patent
1996-06-19
1998-10-27
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
514167, 514557, 514568, 514570, 436 2, G01N 3100, A61K 3159, A61K 3119
Patent
active
058275002
ABSTRACT:
The present invention relates to a process for identifying RAR-antagonist molecules, characterized in that it comprises the following steps: (i) a sufficient amount of an RAR-agonist molecule is applied topically to a part of the skin of a mammal, (ii) a molecule capable of having an RAR-antagonist activity is administered systemically or topically to this same mammal, or to this same part of the skin of the mammal, before, during or after step (i), and (iii) the response on that part of the skin of the mammal thus treated is evaluated.
REFERENCES:
patent: 4889847 (1989-12-01), Kligman
patent: 4992468 (1991-02-01), Chandraratna
patent: 5091518 (1992-02-01), Sucov et al.
patent: 5141959 (1992-08-01), Carroll et al.
patent: 5612356 (1997-03-01), Yoshimura et al.
patent: 5658949 (1997-08-01), Aggarwal
Chandraratna et al., Abstract 242 for 1996 Annual Meeting of Investigative Dermatology, J. Invest. Derm., 106(4), p. 846, Apr. 1996.
Eckhardt et al., Toxicol. Let., 70, pp. 299-308, Feb. 1994.
Giendimenico et al., J. Invest. Derm., 102(5), pp. 676-680, May 1994.
Schiltz et al., J. Invest. Derm., 87(5), pp. 663-667, Nov. 1986.
Standeven et al., Toxicol. & Appl. Pharm., 138(1), pp. 169-175, May 1996.
Biochem. Biophys. Res. Commun., vol. 186, No. 2, pp. 977-983, 1992.
Biochem. Biophys. Res. Commun., vol. 179, No. 3, pp. 1554-1561, 1991.
Analytical Biochemistry, 1988, vol. 171, No. 2, pp. 238-247.
Genes Dev., 1994, vol. 8, No. 24, pp. 3068-3079.
Demarchez Michel
Jomard Andre
Centre International de Recherches Dermatologiques Galderma
Hartley Michael G.
Hollinden Gary E.
LandOfFree
Process for identifying RAR-receptor-antagonist compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for identifying RAR-receptor-antagonist compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for identifying RAR-receptor-antagonist compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1611914